Jing Li
Chief Executive Officer VelaVigo
Experienced Senior Executive with a demonstrated history of working in the pharmaceuticals industry.
Well-established track records of achievement in drug discovery, technology development, and company financials.
Skilled in Biotechnology, Life Sciences, Technology Development, Drug Discovery and Development, and Team Management.
Strong professional graduated from Peking University and Yale University.
Seminars
Thursday 11th June 2026
Advancing First-in-Class & Best-in-Class Multispecific ADC & T-Cell Engager Therapies
2:00 pm
- Leveraging proprietary target mining and drug discovery platforms to enable first-in-class (FIC) and best-in-class (BIC) multispecific biologic development
- Design and development strategy behind multispecific ADC and T-cell engager programs, including differentiation within competitive target landscapes
- Pipeline progression and strategic collaborations supporting clinical translation of multispecific platforms
